Obesity Clinical Trials

10 clinical trials found for Obesity.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 4
40%
N/A 2
20%
Phase 3 2
20%
Phase 4 2
20%

Trial Status Breakdown

Trials for Obesity

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

NCT07497880 · NOT YET RECRUITING · Phase 2

Effectiveness and Safety of Tirzepatide (t.g.) in Patients Treated at the Obesity Unit of the Department of Endocrinology of the Hospital de Clínicas, Faculty of Medical Sciences, UNA: Phase 4 Study

NCT07492563 · NOT YET RECRUITING · N/A

A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities

NCT07467447 · RECRUITING · Phase 2

Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)

NCT07481747 · RECRUITING · Phase 3

A Phase 4 Multicenter, Randomized, Open-Label, Interventional Study With Pragmatic Elements Investigating the Effectiveness of Tirzepatide Once Weekly Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes in a Real-World Setting

NCT07247084 · RECRUITING · Phase 4

Efficacy and Safety of Low-Dose Semaglutide for Weight Loss and Cardiometabolic Improvement in Obese Pakistani Adults Without Type 2 Diabetes: A Single-Arm Open-Label Single-Center Trial

NCT07513168 · RECRUITING · Phase 4

Understanding the Dietary Adjustments Following GLP-1 Agonist Treatment: The GLaD Feasibility Study

NCT07001553 · COMPLETED · N/A

A Phase 2b, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of Multiple Dose Regimens of Once-Weekly Switching to Once-Monthly MET097 in Participants With Obesity or Overweight (VESPER-3)

NCT06973720 · ACTIVE NOT RECRUITING · Phase 2

A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD

NCT06077864 · ACTIVE NOT RECRUITING · Phase 3

The Effects of Glucagon on Hepatic Metabolism

NCT05500586 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Obesity?

There are 10 clinical trials listed for Obesity. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Obesity trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Obesity trials in?

Current Obesity trials are distributed across: Phase 2 (4), N/A (2), Phase 3 (2), Phase 4 (2).

Find More Trials